|
Re: Goldman Sachs
|
|
Resverlogix Corp.
|
Sep 19, 2019 02:19PM
|
|
Re: Goldman Sachs
|
2
|
Resverlogix Corp.
|
Sep 19, 2019 04:29PM
|
|
Re: Games being played on the share price
|
4
|
Resverlogix Corp.
|
May 01, 2019 03:33PM
|
|
Re: Games being played on the share price
|
2
|
Resverlogix Corp.
|
May 01, 2019 06:28PM
|
|
Re: fully adjudicated?
|
2
|
Resverlogix Corp.
|
Apr 19, 2019 10:41AM
|
|
Re: From IR re: Prospectus Offering and Corporate Presentation
|
8
|
Resverlogix Corp.
|
May 23, 2019 07:26PM
|
|
Re: following Hepalink a bit
|
1
|
Resverlogix Corp.
|
Oct 24, 2019 09:35AM
|
|
Re: Financei
|
3
|
Resverlogix Corp.
|
Feb 05, 2020 07:10AM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Mar 03, 2020 09:43AM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Dec 11, 2019 04:19PM
|
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
|
Resverlogix Corp.
|
Mar 12, 2020 11:21AM
|
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
|
Resverlogix Corp.
|
Mar 15, 2020 09:09AM
|
|
Re: FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
3
|
Resverlogix Corp.
|
Mar 15, 2020 10:42AM
|
|
Re: FDA
|
1
|
Resverlogix Corp.
|
Oct 01, 2019 12:28AM
|
|
Re: Expected and unexpected....
|
5
|
Resverlogix Corp.
|
Apr 05, 2019 04:14PM
|
|
Re: Estimated Glomerular Filtration Rate
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 05:51PM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 06:53PM
|
|
Re: ESC TV at ESC Congress 2019 - The Daily Wrap-Up - Tuesday 3 September
|
7
|
Resverlogix Corp.
|
Sep 03, 2019 10:38PM
|
|
Re: ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
4
|
Resverlogix Corp.
|
Sep 03, 2019 05:42PM
|
|
Re: Epigenetics and Coronavirus
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 10:28AM
|
